152 related articles for article (PubMed ID: 27627102)
21. Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers.
Imamura Y; Shimizu K; Yamashita F; Yamaoka K; Takakura Y; Hashida M
Biol Pharm Bull; 2001 Aug; 24(8):930-4. PubMed ID: 11510488
[TBL] [Abstract][Full Text] [Related]
22. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
23. Possible Regulation of P-Glycoprotein Function by Adrenergic Agonists II: Study with Isolated Rat Jejunal Sheets and Caco-2 Cell monolayers.
Mukai H; Takanashi M; Ogawara KI; Maruyama M; Higaki K
J Pharm Sci; 2024 May; 113(5):1209-1219. PubMed ID: 37984697
[TBL] [Abstract][Full Text] [Related]
24. P-glycoprotein attenuating effect of human intestinal fluid.
Deferme S; Tack J; Lammert F; Augustijns P
Pharm Res; 2003 Jun; 20(6):900-3. PubMed ID: 12817895
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of intestinal transport of an organic cation, tributylmethylammonium in Caco-2 cell monolayers.
Hong SS; Moon SC; Shim CK
Arch Pharm Res; 2006 Apr; 29(4):318-22. PubMed ID: 16681038
[TBL] [Abstract][Full Text] [Related]
26. Involvement of cholesterol in the inhibitory effect of dimethyl-beta-cyclodextrin on P-glycoprotein and MRP2 function in Caco-2 cells.
Yunomae K; Arima H; Hirayama F; Uekama K
FEBS Lett; 2003 Feb; 536(1-3):225-31. PubMed ID: 12586368
[TBL] [Abstract][Full Text] [Related]
27. Rhamnolipids enhance epithelial permeability in Caco-2 monolayers.
Jiang L; Long X; Meng Q
Int J Pharm; 2013 Mar; 446(1-2):130-5. PubMed ID: 23402975
[TBL] [Abstract][Full Text] [Related]
28. Midazolam exhibits characteristics of a highly permeable P-glycoprotein substrate.
Tolle-Sander S; Rautio J; Wring S; Polli JW; Polli JE
Pharm Res; 2003 May; 20(5):757-64. PubMed ID: 12751631
[TBL] [Abstract][Full Text] [Related]
29. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
[TBL] [Abstract][Full Text] [Related]
30. Effects of budesonide on P-glycoprotein expression in intestinal cell lines.
Maier A; Zimmermann C; Beglinger C; Drewe J; Gutmann H
Br J Pharmacol; 2007 Feb; 150(3):361-8. PubMed ID: 17179942
[TBL] [Abstract][Full Text] [Related]
31. Transport of 5,5-diphenylbarbituric acid and its precursors and their effect on P-gp, MRP2 and CYP3A4 in Caco-2 and LS180 cells.
Fan J; Maeng HJ; Du Y; Kwan D; Pang KS
Eur J Pharm Sci; 2011 Jan; 42(1-2):19-29. PubMed ID: 20955791
[TBL] [Abstract][Full Text] [Related]
32. Transepithelial transport of Cerulenin across Caco-2 cell monolayers.
Fu DH; Liu ZL; Liu JS; Luo Y; Shu Y; Huang SH; Han ZM
Eur J Drug Metab Pharmacokinet; 2009; 34(2):67-72. PubMed ID: 19645214
[TBL] [Abstract][Full Text] [Related]
33. Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport.
Liao ZG; Tang T; Guan XJ; Dong W; Zhang J; Zhao GW; Yang M; Liang XL
Molecules; 2016 Nov; 21(12):. PubMed ID: 27886150
[TBL] [Abstract][Full Text] [Related]
34. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
Neuhoff S; Ungell AL; Zamora I; Artursson P
Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
[TBL] [Abstract][Full Text] [Related]
35. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: Impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure.
Al-Ali AAA; Steffansen B; Holm R; Nielsen CU
Int J Pharm; 2018 Nov; 551(1-2):270-280. PubMed ID: 30240828
[TBL] [Abstract][Full Text] [Related]
36. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effects of mitragynine on P-glycoprotein in vitro.
Rusli N; Amanah A; Kaur G; Adenan MI; Sulaiman SF; Wahab HA; Tan ML
Naunyn Schmiedebergs Arch Pharmacol; 2019 Apr; 392(4):481-496. PubMed ID: 30604191
[TBL] [Abstract][Full Text] [Related]
38. Relationship between structure and permeability of dipeptide derivatives containing tryptophan and related compounds across human intestinal epithelial (Caco-2) cells.
Ano R; Kimura Y; Urakami M; Shima M; Matsuno R; Ueno T; Akamatsu M
Bioorg Med Chem; 2004 Jan; 12(1):249-55. PubMed ID: 14697790
[TBL] [Abstract][Full Text] [Related]
39. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
Behrens I; Kissel T
Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
[TBL] [Abstract][Full Text] [Related]
40. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
